Merck says cholesterol drug Tredaptive failed to show benefits, will not seek US approval

  • by: Associated Press
  • Updated: December 20, 2012 - 10:51 AM

WHITEHOUSE STATION, N.J. - Drugmaker Merck & Co. said it will not seek U.S. approval for its cholesterol drug Tredaptive and is recommending doctors abroad stop prescribing it to new patients, based on failed study results.

  • 0
  • Comments

There are currently no comments for this article

Comment on this story   |   Be the first to comment

Be the first to comment

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT